219 related articles for article (PubMed ID: 20980456)
1. Levels of oxidized LDL and advanced glycation end products-modified LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes.
Lopes-Virella MF; Hunt KJ; Baker NL; Lachin J; Nathan DM; Virella G;
Diabetes; 2011 Feb; 60(2):582-9. PubMed ID: 20980456
[TBL] [Abstract][Full Text] [Related]
2. Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes.
Hunt KJ; Baker N; Cleary P; Backlund JY; Lyons T; Jenkins A; Virella G; Lopes-Virella MF;
Atherosclerosis; 2013 Dec; 231(2):315-22. PubMed ID: 24267245
[TBL] [Abstract][Full Text] [Related]
3. Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes.
Lopes-Virella MF; McHenry MB; Lipsitz S; Yim E; Wilson PF; Lackland DT; Lyons T; Jenkins AJ; Virella G;
Atherosclerosis; 2007 Feb; 190(2):359-69. PubMed ID: 16530770
[TBL] [Abstract][Full Text] [Related]
4. Effect of intensive diabetes treatment on carotid artery wall thickness in the epidemiology of diabetes interventions and complications. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.
Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
Diabetes; 1999 Feb; 48(2):383-90. PubMed ID: 10334318
[TBL] [Abstract][Full Text] [Related]
5. Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.
Polak JF; Backlund JY; Cleary PA; Harrington AP; O'Leary DH; Lachin JM; Nathan DM;
Diabetes; 2011 Feb; 60(2):607-13. PubMed ID: 21270271
[TBL] [Abstract][Full Text] [Related]
6. High levels of oxidized LDL in circulating immune complexes are associated with increased odds of developing abnormal albuminuria in Type 1 diabetes.
Lopes-Virella MF; Carter RE; Baker NL; Lachin J; Virella G;
Nephrol Dial Transplant; 2012 Apr; 27(4):1416-23. PubMed ID: 21856760
[TBL] [Abstract][Full Text] [Related]
7. Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness.
Lyons TJ; Jenkins AJ; Zheng D; Klein RL; Otvos JD; Yu Y; Lackland DT; McGee D; McHenry MB; Lopes-Virella M; Garvey WT;
Diabet Med; 2006 Sep; 23(9):955-66. PubMed ID: 16922701
[TBL] [Abstract][Full Text] [Related]
8. The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study.
Lopes-Virella MF; Hunt KJ; Baker NL; Virella G; Moritz T;
Atherosclerosis; 2012 Oct; 224(2):526-31. PubMed ID: 22963984
[TBL] [Abstract][Full Text] [Related]
9. Antibodies against various forms of mildly oxidized low-density lipoprotein are not associated with carotid intima-media thickness in patients with primary hyperlipidemia.
Tsouli SG; Kiortsis DN; Xydis V; Argyropoulou MI; Elisaf M; Tselepis AD
Angiology; 2006; 57(5):615-22. PubMed ID: 17067985
[TBL] [Abstract][Full Text] [Related]
10. [Oxidized LDL and C-reactive protein level in relation to carotid intima-media thickness in population with risk factors for atherosclerosis].
Caparević Z; Kostić N; Ilić S; Radojković J; Marina Dj; Pencić B; Radojković I
Srp Arh Celok Lek; 2009; 137(3-4):140-5. PubMed ID: 19459559
[TBL] [Abstract][Full Text] [Related]
11. Carotid artery intima-media thickness in children with type 1 diabetes.
Järvisalo MJ; Putto-Laurila A; Jartti L; Lehtimäki T; Solakivi T; Rönnemaa T; Raitakari OT
Diabetes; 2002 Feb; 51(2):493-8. PubMed ID: 11812760
[TBL] [Abstract][Full Text] [Related]
12. Impact of low-density lipoprotein particle size on carotid intima-media thickness in patients with type 2 diabetes mellitus.
Hayashi Y; Okumura K; Matsui H; Imamura A; Miura M; Takahashi R; Murakami R; Ogawa Y; Numaguchi Y; Murohara T
Metabolism; 2007 May; 56(5):608-13. PubMed ID: 17445534
[TBL] [Abstract][Full Text] [Related]
13. High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes.
Lopes-Virella MF; Baker NL; Hunt KJ; Lyons TJ; Jenkins AJ; Virella G;
Diabetes Care; 2012 Jun; 35(6):1333-40. PubMed ID: 22511260
[TBL] [Abstract][Full Text] [Related]
14. High levels of AGE-LDL, and of IgG antibodies reacting with MDA-lysine epitopes expressed by oxLDL and MDA-LDL in circulating immune complexes predict macroalbuminuria in patients with type 2 diabetes.
Lopes-Virella MF; Hunt KJ; Baker NL; Virella G;
J Diabetes Complications; 2016; 30(4):693-9. PubMed ID: 26861948
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population.
Fukumoto M; Shoji T; Emoto M; Kawagishi T; Okuno Y; Nishizawa Y
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):703-7. PubMed ID: 10712394
[TBL] [Abstract][Full Text] [Related]
16. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.
Nathan DM; Lachin J; Cleary P; Orchard T; Brillon DJ; Backlund JY; O'Leary DH; Genuth S; ;
N Engl J Med; 2003 Jun; 348(23):2294-303. PubMed ID: 12788993
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis.
Karvonen J; Päivänsalo M; Kesäniemi YA; Hörkkö S
Circulation; 2003 Oct; 108(17):2107-12. PubMed ID: 14530200
[TBL] [Abstract][Full Text] [Related]
18. Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes.
Lopes-Virella MF; Baker NL; Hunt KJ; Lachin J; Nathan D; Virella G;
Atherosclerosis; 2011 Feb; 214(2):462-7. PubMed ID: 21156319
[TBL] [Abstract][Full Text] [Related]
19. Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes.
Katakami N; Matsuhisa M; Kaneto H; Matsuoka TA; Sakamoto K; Yasuda T; Umayahara Y; Kosugi K; Yamasaki Y
Atherosclerosis; 2009 May; 204(1):288-92. PubMed ID: 18926539
[TBL] [Abstract][Full Text] [Related]
20. Plasma interleukin-5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis.
Sämpi M; Ukkola O; Päivänsalo M; Kesäniemi YA; Binder CJ; Hörkkö S
J Am Coll Cardiol; 2008 Oct; 52(17):1370-8. PubMed ID: 18940525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
